operating grant: innovative biomedical and clinical hiv/aids research
the operating grant: innovative biomedical and clinical hiv/aids research will support innovative or high-risk biomedical and clinical research directly relevant to the priority objectives of the cihr hiv/aids research initiative.
the specific objectives of the funding opportunity are to:
- enable new and established investigators to undertake innovative research projects in new areas of investigation or take previous discoveries in new directions;
- promote the development and testing of novel research tools and methodologies); and
- support high-risk research projects with the potential for high impact, breakthrough and/or transformative advances.
relevant research areas
- biology of early hiv infection, pathogenesis and immunology relevant to the identification of new immunogens, correlates of protection and other aspects of hiv prevention.
- host and viral factors influencing hiv persistence (including viral latency) and viral reservoirs; creating models (cellular and animal) of hiv latency and assays to measure persistent hiv infection; and other aspects of hiv cure strategies.
- approaches to vaccine development including novel adjuvants and platforms for immunization.
- virological and biological aspects of aging and co-morbid conditions (e.g., chronic diseases and co-infections) for people living with hiv.